RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--March 3, 2005--Bayer Biological Products (Bayer BP) today launched www.KogenateFS.com. The new Web site seeks to educate the hemophilia community about Kogenate(R) FS (Antihemophilic Factor (Recombinant), Formulated with Sucrose), and the array of Bayer BP-supported programs and services that help people living with hemophilia lead full, active, and productive lives. The site also provides in-depth information on hemophilia and the latest on disease management. The Web site offers a dedicated section for patients and caregivers, and another section for health care professionals allowing users an educationally focused experience. Patients and caregivers can view content ranging from basic facts about living with hemophilia, to videos with information on everything from the manufacturing of a recombinant Factor VIII (FVIII) molecule to its mechanism of action at the site of a bleed. Health care professionals can benefit from having access to information regarding the latest publications and ongoing research into the next generation of hemophilia therapies. They also have access to the latest patient education materials.
